全球體外膜氧合（ECMO）市場：市場規模、佔有率和趨勢分析（2026-2032）

全球體外膜氧合（ECMO）市場報告（至2032年）

2025年，全球體外膜氧合（ECMO）市場規模為9,900萬美元。預計到2032年，該市場將以7.9%的複合年成長率成長，達到1.69億美元。

本報告涵蓋全球 ECMO（體外膜氧合）市場，包括用於提供高級心肺支援的拋棄式套件和 ECMO 設備。

分析包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要受心血管疾病和嚴重呼吸系統疾病發病率上升、冠狀動脈疾病盛行率增加以及醫生對體外膜氧合（ECMO）應用的認知不斷加深所驅動。然而，價格競爭以及心室輔助裝置（VAD）和心肺體外迴圈機等替代療法的出現預計將限制市場進一步成長。

市場概覽

全球體外膜氧合（ECMO）市場涵蓋用於為嚴重患者提供臨時性心肺支援的設備。當心臟和肺功能不全時，ECMO系統會透過將氧氣輸送到體外血液並再輸回患者體內，來支持循環和氣體交換。

該市場包括體外膜氧合（ECMO）設備和ECMO耗材。設備是指運作此系統所需的固定資產，而耗材包括氧合器、管路套件、過濾器以及治療過程中所需的其他一次性零件。

ECMO（體外膜氧合）應用的持續成長是由全球心血管疾病和嚴重呼吸系統疾病的增加所驅動的。冠狀動脈疾病、心臟衰竭和急性呼吸系統疾病發生率的上升，使得需要高級生命支持的潛在患者群體不斷擴大。

這一趨勢表明，ECMO治療在預測期內將保持溫和成長。然而，市場競爭日益激烈，各地區的公司都在進行價格戰。儘管ECMO的使用率不斷提高，但這種價格壓力預計仍將抑制市場總值的成長。

市場促進因素

冠狀動脈疾病發生率上升

冠狀動脈疾病發生率的上升是體外膜氧合（ECMO）技術引入的主要促進因素。冠狀動脈疾病與老齡化密切相關，並且仍然是全球主要死因之一。

隨著世界老年人口的成長，患有嚴重心血管疾病的人數也預計將增加。根據聯合國預測，到2050年，80歲以上人口數量將達到4.26億，高於2019年的1.43億。

人口結構的變化預計將增加對先進心臟支持技術的需求。體外膜氧合（ECMO）設備及其耗材用於某些危重病例，這些患者需要暫時的輔助治療，因此心血管疾病的盛行率是重要的長期成長要素。

嚴重呼吸系統疾病的負擔

嚴重的呼吸系統疾病也是推動體外膜氧合（ECMO）治療普及的關鍵因素。 ECMO可用於常規治療無法充分支持的急性呼吸系統疾病患者。

隨著醫療系統識別和治療嚴重呼吸衰竭的能力不斷提高，體外膜氧合（ECMO）在專科重症監護環境中的應用可能會更加頻繁。這將增加對ECMO設備和耗材的需求。

此外，ECMO作為一種先進的生命維持療法，其日益受到認可，這也推動了市場成長。擁有成熟重症監護和心臟外科手術計畫的醫院，可能會繼續擴大其ECMO基礎設施，將其作為更廣泛的心肺支持服務的一部分。

易用性和醫生熟練程度

易用性和醫生熟練程度是體外膜氧合（ECMO）市場的主要促進因素。大多數心臟外科醫生都熟練ECMO的實施，而且越來越多的循環系統也開始涉足這一領域。

由於許多循環系統和心臟專家都了解如何使用體外膜氧合（ECMO），ECMO產品擁有龐大且不斷成長的臨床應用基礎。這種熟悉度推動了ECMO的普及，並有助於維持對療法的需求。

隨著越來越多的醫生累積ECMO經驗，其應用範圍可能會擴展到專科醫院和先進醫療中心。這將促進一次性產品的銷售，並在預測期內刺激對ECMO設備的投資。

市場限制

選擇

替代療法仍然是體外膜氧合（ECMO）市場發展的重大限制因素。在某些患者群體中，心室輔助裝置（VAD）作為ECMO的治療方法方案正變得越來越受歡迎。

心室輔助裝置（VAD）可提供機械循環支持，根據患者病情、所需支持時間和臨床目標，在某些情況下，VAD 可能優於體外膜氧合（ECMO）。預計在預測期內，VAD 的成長將抑制 ECMO 市場的擴張。

心肺體外迴圈裝置是另一種可能限制體外膜氧合（ECMO）發展前景的替代方案。雖然ECMO具有特定的臨床應用，但其他輔助治療技術的存在可能會減少ECMO作為首選方案的病例數。

競爭壓力

競爭壓力預計將抑制市場成長。在全球體外膜氧合（ECMO）市場，尤其是在多家老字型大小企業和本地供應商活躍的地區，各企業之間展開了激烈的價格競爭。

競爭可能會逐步降低體外膜氧合（ECMO）設備的平均售價（ASP）。這將對設備本身和一次性耗材都產生影響，尤其是在醫院密切比較產品成本的情況下。

即使手術量增加，平均售價（ASP）的下降也可能減緩收入成長。預計這種價格壓力將在整個預測期內持續存在，從而抑制體外膜氧合（ECMO）市場的整體價值。

資本設備方面的限制

ECMO設備需要資金投入，這可能會限制預算緊張的醫院採用該設備。一次性產品可以帶來持續的收入，而設備的採購則取決於醫療機構的資源、預期的手術量以及重症監護基礎設施。

小規模的醫院和ECMO設備有限的醫療機構可能不願意投資購買新系統。即使有臨床需求，ECMO的實施也可能集中在擁有訓練有素的團隊和完善的患者照護流程的先進醫療中心。

這對市場進一步擴張造成了障礙。製造商需要平衡設備安裝、一次性耗材的使用、培訓和服務支持，以建立永續的體外膜氧合（ECMO）計畫。

市場覆蓋範圍和數據範圍

• 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
• 定性範圍：市場促進因素和阻礙因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
• 週期：基準年為 2025 年，預測至 2032 年，歷史資料至 2022 年。
• 建立市場模型：根據治療量、競爭市場佔有率分析和預測假設，使用銷售量和平均售價 (ASP) 分析收入。
• 目標設備：本報告涵蓋體外膜氧合（ECMO）設備，包括 ECMO 機器和用於高階心臟和呼吸支援的拋棄式產品。

目標市場及區隔

體外膜氧合（ECMO）市場

• 設備類型：拋棄式產品和用於體外膜氧合（ECMO）的 ECMO 設備。

ECMO拋棄式包括ECMO治療期間所需的一次性組件。這些組件包括氧合器、管路套件、過濾器以及其他用於支援體外血液氧合和循環的拋棄式產品。

ECMO設備包括用於ECMO支援運作的大型設備。這些系統控制血流、支持氧合，並協助對重症患者進行暫時心肺支持。

每個細分市場都根據市場規模、市場佔有率、治療次數、市場預測、市場成長率、銷售量和平均售價進行分析。

這種市場細分使製造商、投資者和策略團隊能夠了解一次性產品的活用狀況、設備部署、重症監護接受能力、疾病負擔、醫生知識水平和價格競爭壓力等因素如何塑造全球 ECMO 市場。

競爭分析

截至2025年，美敦力是全球體外膜氧合（ECMO）市場的領導者。其醫療設備產品線包括Affinity®和Minimax®氧合系統。

此外，美敦力還提供一次性產品，並在未來幾年內擁有擴大市場佔有率的空間。其在大型設備和一次性產品領域的雙重佈局，增強了公司的競爭力，使其能夠滿足醫院多樣化的體外膜氧合（ECMO）採購需求。

2025年，Getinge是全球ECMO市場第二大公司。該公司提供一次性產品和設備，企業發展遍及全球。

隨著使用體外膜氧合（ECMO）的患者數量增加，Getinge有望擴大其市場佔有率。該公司豐富的產品系列以及與醫院的牢固合作關係，為其持續進軍不斷成長的ECMO市場提供了有力支撐。

2025 年，泰爾茂是全球 ECMO 市場第三大競爭對手。該公司提供全面的 ECMO 相關一次性產品組合，包括 CAPIOX® 系列氧合器、客製化管路套件和過濾器。

泰爾茂種類繁多的耗材產品使其在多個地區保持競爭優勢。然而，隨著市場區隔加劇和價格壓力增大，競爭格局將持續變化。

技術和臨床趨勢

使用一次性試劑盒

由於每項手術都需要一次性組件，因此一次性耗材包在體外膜氧合（ECMO）市場價值中扮演核心角色。隨著ECMO使用量的增加，對氧化劑、管路組件、過濾器及相關一次性產品的需求也預計將上升。

即使設備購置有限，也能確保持續的收入。

擴展高級生命維持程序

體外膜氧合（ECMO）在專科心臟和重症監護環境中正日益成為高級生命支持治療的重要組成部分。嚴重心臟和呼吸系統疾病發生率的上升推動了其應用範圍的擴大。

已建立體外膜氧合（ECMO）計畫的醫院預計將繼續成為該計畫實施的主要中心。

醫生的技能水平

大多數心臟外科醫生都熟練體外膜氧合（ECMO）的設置方法，越來越多的循環系統也開始涉足這一領域。不斷擴大的受訓用戶群體正在推動ECMO的更廣泛應用。

接受 ECMO 工作流程的培訓和熟練度對於該手術的廣泛應用仍然至關重要。

價格優惠

價格競爭是關鍵的市場趨勢。隨著全球競爭加劇，平均售價（ASP）預計將持續面臨壓力。

即使需求增加，這也可能限制市場價值的成長。

ECMO 與 VAD 的比較

對於某些患者而言，心室輔助裝置（VAD）仍然是體外膜氧合（ECMO）的重要替代方案。裝置的選擇取決於所需支援的類型、預期使用時間以及患者的病情。

這種競爭態勢未來可能會持續影響體外膜氧合（ECMO）技術的應用。

設備安裝和程式開發

ECMO設備的實施取決於醫院的基礎設施、臨床團隊的準備以及預期使用量。重症監護病例量大的醫療機構更有可能支持永續的ECMO計畫。

設備部署策略必須與使用一次性零件、培訓和長期服務支援一致。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份報告的意義

• 全球體外膜氧合（ECMO）市場目前的規模有多大？預計到 2032 年將成長多少？
• 在預測期內，ECMO拋棄式產品和ECMO設備的性能將如何進行評估？
• 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
• ECMO在高階心臟和呼吸支持中發揮什麼作用？
• 心臟疾病率的上升對體外膜氧合（ECMO）的應用有何影響？
• 人口老化對先進維生技術的需求有何影響？
• 為什麼醫師對體外膜氧合（ECMO）的了解能夠促進ECMO市場的成長？
• 人工心臟（VAD）和心肺體外迴圈（ECMO）的引入產生了哪些影響？
• 價格競爭壓力如何影響市場價值？
• 全球體外膜氧合（ECMO）市場的主要參與者有哪些？

iData Research 的《全球體外膜氧合 (ECMO) 市場報告》透過設備層級分析、基於流程的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、對標競爭對手、了解心肺支援趨勢，並協助您制定全球 ECMO 市場的產業計畫。

目錄

調查方法

• 第一步：專案啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 第四步：進行初步調查
• 第五步：調查與分析：建立基準估計值
• 第六步：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟九：客戶回饋與市場監測

全球關稅的影響

體外膜氧合器市場

• 執行摘要
  • 全球體外膜氧合市場概覽
  • 競爭分析
  • 目標程式
  • 目標市場
  • 目標區域
• 介紹
• 手術次數
  • 全身體外膜氧合（ECMO）手術次數
  • ECMO手術次數（依方式分類）
  • ECMO手術次數（依應用領域）
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • ECMO一次性產品市場
  • ECMO設備市場
• 促進因素和抑制因素
• 競爭性市佔率分析

附錄

Global Extracorporeal Membrane Oxygenation Market Report to 2032

The global extracorporeal membrane oxygenation market was valued at $99 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 7.9%, reaching $169 million by 2032.

This report covers the global market for extracorporeal membrane oxygenation (ECMO), including ECMO disposable kits and ECMO machines used to provide advanced cardiac and respiratory support.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by the rising incidence of cardiovascular and severe respiratory diseases, increasing coronary heart disease prevalence, and broad physician familiarity with ECMO placement. However, alternatives such as VADs and heart-lung machines, along with competitive pricing pressure, are expected to limit stronger market value growth.

Market Overview

The global extracorporeal membrane oxygenation market includes devices used to provide temporary cardiac and respiratory support for critically ill patients. ECMO systems oxygenate blood outside the body and return it to the patient, supporting circulation and gas exchange when the heart or lungs are unable to function adequately.

The market includes ECMO machines and ECMO disposables. Machines represent the capital equipment used to run the system, while disposables include oxygenators, tubing kits, filters, and other single-use components needed during treatment.

Ongoing growth in ECMO utilization is supported by the rising global incidence of cardiovascular and severe respiratory diseases. Increasing rates of coronary heart disease, heart failure, and acute respiratory conditions have expanded the potential patient population requiring advanced life support.

This trend is expected to sustain moderate growth in ECMO procedures over the forecast period. However, the market is also becoming more competitive, with firms competing on price across several regions. This pricing pressure is expected to limit total market value growth despite rising utilization.

Market Drivers

Increasing Incidence of Coronary Heart Disease

The increasing incidence of coronary heart disease is a major driver of ECMO adoption. Coronary heart disease is strongly associated with age and remains one of the leading causes of death worldwide.

As the global geriatric population increases, the number of patients at risk for severe cardiovascular disease is expected to grow. According to the United Nations, the number of people aged 80 years or older is projected to reach 426 million by 2050, up from 143 million in 2019.

This demographic shift is expected to increase demand for advanced cardiac support technologies. ECMO machines and disposables are used in selected high-acuity cases where patients require temporary support, making cardiovascular disease prevalence an important long-term growth factor.

Severe Respiratory Disease Burden

Severe respiratory disease is another important driver of ECMO procedure growth. ECMO can be used for patients with acute respiratory conditions when conventional support is not sufficient.

As healthcare systems improve their ability to identify and treat severe respiratory failure, ECMO may be used more often in specialized critical care settings. This supports demand for both machines and recurring disposable kits.

The market is also supported by broader awareness of ECMO as an advanced life support option. Hospitals with established critical care and cardiac surgery programs may continue expanding ECMO capabilities as part of broader cardiopulmonary support services.

Ease of Use and Physician Familiarity

Ease of use and physician familiarity are key drivers in the ECMO market. Most cardiac surgeons are familiar with placing ECMO in a patient, and a growing number of cardiologists are entering the field.

Since many cardiologists and cardiac specialists understand how to use ECMO, there is a large and growing clinical base for ECMO products. This familiarity supports adoption and helps maintain procedural demand.

As more physicians gain experience with ECMO, access may expand across specialized hospitals and advanced care centers. This can support unit sales of disposables and encourage investment in ECMO machines over the forecast period.

Market Limiters

Alternatives

Alternatives remain an important limiter for the ECMO market. Ventricular assist devices are a popular and growing treatment alternative to ECMO in certain patient groups.

VADs can provide mechanical circulatory support and may be preferred in some cases depending on patient condition, duration of support required, and clinical goals. Their growth is expected to stifle ECMO market expansion over the forecast period.

Heart-lung machines are another alternative that may limit ECMO growth. Although ECMO has specific clinical applications, competing support technologies can reduce the number of cases where ECMO is selected as the preferred option.

Competitive Pressures

Competitive pressures are expected to limit market value growth. Firms across the global ECMO market compete on price, particularly in regions where multiple established companies and local suppliers are active.

Competition between companies has the potential to drive a steady decrease in ASPs for ECMO devices. This affects both machines and disposables, especially when hospitals compare product costs closely.

Even if procedure volumes rise, lower ASPs can reduce revenue growth. This pricing pressure is expected to continue over the forecast period and limit the total value of the ECMO market.

Capital Equipment Constraints

ECMO machines require capital investment, which can limit adoption in hospitals with constrained budgets. While disposables generate recurring revenue, machine purchases depend on facility resources, procedure volume expectations, and critical care infrastructure.

Smaller hospitals or facilities with limited ECMO utilization may be cautious about investing in new systems. Even when clinical need exists, adoption may be concentrated in advanced centers with trained teams and established patient pathways.

This creates a barrier to broader market expansion. Manufacturers must balance machine placement, disposable utilization, training, and service support to build sustainable ECMO programs.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers extracorporeal membrane oxygenation devices, including ECMO machines and ECMO disposables used for advanced cardiac and respiratory support.

Markets Covered and Segmentation

Extracorporeal Membrane Oxygenation Market

• Device type: ECMO disposables and ECMO machines.

ECMO disposables include single-use components required during ECMO procedures. These may include oxygenators, tubing kits, filters, and other disposable products used to support blood oxygenation and circulation outside the body.

ECMO machines include the capital systems used to operate ECMO support. These systems control blood flow, support oxygenation, and help manage temporary cardiopulmonary support in critically ill patients.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how disposable utilization, machine adoption, critical care capacity, disease burden, physician familiarity, and competitive pricing pressure are shaping the global ECMO market.

Competitive Analysis

Medtronic was the leading company in the global ECMO market in 2025. The company's capital equipment product line includes the Affinity(R) and Minimax(R) oxygenation systems.

Medtronic also offers disposable products, giving it room to expand its market presence over the coming years. Its participation across both capital and disposable categories supports its competitive position and allows the company to serve hospitals across different ECMO purchasing needs.

Getinge was the second-leading company in the global ECMO market in 2025. The company offers both disposables and machines and has a global presence.

As the number of patients able to access ECMO rises, Getinge is expected to gain some share. Its broad cardiopulmonary support portfolio and established hospital relationships support continued participation in ECMO growth.

Terumo was the third-leading competitor in the global ECMO market in 2025. The company offers its CAPIOX(R) line of oxygenators, along with a comprehensive portfolio of ECMO-related disposable products, including custom tubing kits and filters.

Terumo's broad consumables offering supports its competitive positioning across multiple regions. However, increasing market fragmentation and pricing pressure will continue to shape competitive dynamics.

Technology and Practice Trends

Disposable Kit Utilization

Disposable kits are central to ECMO market value because each procedure requires single-use components. As ECMO utilization rises, demand for oxygenators, tubing kits, filters, and related disposables is expected to increase.

This supports recurring revenue even when machine purchases are more limited.

Growth in Advanced Life Support

ECMO is becoming a more important part of advanced life support in specialized cardiac and critical care settings. Rising rates of severe cardiac and respiratory disease are supporting broader use.

Hospitals with established ECMO programs are expected to remain key adoption centers.

Physician Familiarity

Most cardiac surgeons are familiar with ECMO placement, and more cardiologists are entering the field. This growing base of trained users supports broader adoption.

Training and comfort with ECMO workflows will remain important to procedure growth.

Competitive Pricing

Competitive pricing is an important market trend. As more companies compete globally, ASP pressure is expected to continue.

This may limit market value growth even when unit demand increases.

ECMO Versus VADs

VADs remain an important alternative to ECMO in certain patients. Device selection depends on the type of support required, expected duration of use, and patient condition.

This competition will continue to influence ECMO adoption.

Machine Placement and Program Development

ECMO machine adoption depends on hospital infrastructure, clinical team readiness, and expected utilization. Facilities with higher critical care volumes are more likely to support sustainable ECMO programs.

Machine placement strategies must be aligned with disposable usage, training, and long-term service support.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global extracorporeal membrane oxygenation market today, and how much is it expected to grow through 2032?
• How are ECMO disposables and ECMO machines performing across the forecast period?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• What role does ECMO play in advanced cardiac and respiratory support?
• How is the rising incidence of coronary heart disease affecting ECMO adoption?
• How is the growing elderly population influencing demand for advanced life support technologies?
• Why does physician familiarity support ECMO market growth?
• How are VADs and heart-lung machines affecting ECMO adoption?
• What impact does competitive pricing pressure have on market value?
• Which companies lead the global ECMO market?

The Global Extracorporeal Membrane Oxygenation Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand cardiopulmonary support trends, and support commercial planning in the global ECMO market.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Extracorporeal Membrane Oxygenation Market

• 26.1 Executive Summary
  • 26.1.1 Global Extracorporeal Membrane Oxygenation Market Overview
  • 26.1.2 Competitive Analysis
  • 26.1.3 Procedures Included
  • 26.1.4 Markets Included
  • 26.1.5 Regions Included
• 26.2 Introduction
• 26.3 Procedure Numbers
  • 26.3.1 Total Extracorporeal Membrane Oxygenation Procedures
  • 26.3.2 ECMO Procedures By Modality
    • 26.3.2.1 Venoarterial ECMO Procedures
    • 26.3.2.2 Venovenous ECMO Procedures
    • 26.3.2.3 Arteriovenous ECMO Procedures
  • 26.3.3 ECMO Procedures By Application
    • 26.3.3.1 Respiratory ECMO Procedures
    • 26.3.3.2 Cardiac ECMO Procedures
    • 26.3.3.3 ECPR ECMO Procedures
• 26.4 Market Overview
  • 26.4.1 By Segment
  • 26.4.2 By Region
• 26.5 Market Analysis And Forecast
  • 26.5.1 ECMO Disposables Market
  • 26.5.2 ECMO Machine Market
• 26.6 Drivers And Limiters
  • 26.6.1 Market Drivers
  • 26.6.2 Market Limiters
• 26.7 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

• Chart 26-1: Extracorporeal Membrane Oxygenation Market, Global, 2025 & 2032
• Chart 26-2: Extracorporeal Membrane Oxygenation Procedures, Global, 2025
• Chart 26-3: Extracorporeal Membrane Oxygenation Procedures by Modality, Global, 2022 - 2032
• Chart 26-4: Extracorporeal Membrane Oxygenation Procedures by Application, Global, 2022 - 2032
• Chart 26-5: Extracorporeal Membrane Oxygenation Market by Segment, Global, 2022 - 2032
• Chart 26-6: Extracorporeal Membrane Oxygenation Device Market by Region, Global, 2022 - 2032
• Chart 26-7: Leading Competitors, Extracorporeal Membrane Oxygenation Market, Global, 2025

LIST OF FIGURES

• Figure 26-1: Extracorporeal Membrane Oxygenation Procedures Covered
• Figure 26-2: Extracorporeal Membrane Oxygenation Markets Covered
• Figure 26-3: Extracorporeal Membrane Oxygenation Market Regions Covered, Global (1 of 2)
• Figure 26-4: Extracorporeal Membrane Oxygenation Market Regions Covered, Global (2 of 2)
• Figure 26-5: Extracorporeal Membrane Oxygenation Procedures by Region, Global, 2022 - 2032
• Figure 26-6: Extracorporeal Membrane Oxygenation Procedures by Modality, Global, 2022 - 2032
• Figure 26-7: Venoarterial ECMO Procedures by Region, Global, 2022 - 2032
• Figure 26-8: Venovenous ECMO Procedures by Region, Global, 2022 - 2032
• Figure 26-9: Arteriovenous ECMO Procedures by Region, Global, 2022 - 2032
• Figure 26-10: Extracorporeal Membrane Oxygenation Procedures by Modality, Global, 2022 - 2032
• Figure 26-11: Respiratory ECMO Procedures by Region, Global, 2022 - 2032
• Figure 26-12: Cardiac ECMO Procedures by Region, Global, 2022 - 2032
• Figure 26-13: eCPR ECMO Procedures by Region, Global, 2022 - 2032
• Figure 26-14: Extracorporeal Membrane Oxygenation Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 26-15: Extracorporeal Membrane Oxygenation Market by Region, Global, 2022 - 2032 (US$M)
• Figure 26-16: ECMO Disposables Market, Global, 2022 - 2032
• Figure 26-17: Units Sold by Region, ECMO Disposables Market, Global, 2022 - 2032
• Figure 26-18: Average Selling Price by Region, ECMO Disposables Market, Global, 2022 - 2032 (US$)
• Figure 26-19: Market Value by Region, ECMO Disposables Market, Global, 2022 - 2032 (US$M)
• Figure 26-20: ECMO Machine Market, Global, 2022 - 2032
• Figure 26-21: Units Sold by Region, ECMO Machine Market, Global, 2022 - 2032
• Figure 26-22: Average Selling Price by Region, ECMO Machine Market, Global, 2022 - 2032 (US$)
• Figure 26-23: Market Value by Region, ECMO Machine Market, Global, 2022 - 2032 (US$M)
• Figure 26-24: Leading Competitors, Extracorporeal Membrane Oxygenation Market, Global, 2025